April 2009
Volume 50, Issue 13
ARVO Annual Meeting Abstract  |   April 2009
Effects of Blue-Light Blocking Filters on Visual Function in Age-Related Macular Degeneration
Author Affiliations & Notes
  • S. Asonuma
    Osaka University Medical School, Suita, Japan
  • T. Fujikado
    Applied Visual Science,
    Osaka University Medical School, Suita, Japan
  • Footnotes
    Commercial Relationships  S. Asonuma, None; T. Fujikado, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3762. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Asonuma, T. Fujikado; Effects of Blue-Light Blocking Filters on Visual Function in Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3762.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To evaluate objectively the effect of blue-light blocking filters (BLBF) on visual function of patients with age-related macular degeneration (AMD) by measuring contrast sensitivity (CS) and best-corrected visual acuity (BCVA).

Methods: : Thirty seven patients with AMD (AMD group) and 8 age-matched subjects with normal vision (NV group) were examined. We measured CS using a letter chart (Vector Vision) and BCVA before and after wearing BLBF (CCP; blocking <500 nm, CCP400; blocking <400 nm, TOKAI) or neutral density filters (NDF) of similar ND value, under conditions with or without glare. We compared changes in CS 1) with BLBF vs. NDF, 2) in AMD group vs. NV group, and 3) in cataract group vs. intraocular lens (IOL) group in AMD. We measured BCVA with ETDRS chart.

Results: : In patients with AMD, CS and BCVA improved by wearing BLBF under both with or without glare condition. The improvement in CS with CCP and CCP400 was significantly better than with NDF in the condition without glare (ΔlogCS: 0.15 vs. 0.06 (CCP vs. NDF, p=0.03); 0.13 vs. 0.03 (CCP400 vs. NDF, p=0.008)). The improvement in CS and BCVA with CCP400 was significant (ΔlogCS: 0.23 (p<0.001); ΔBCVA: 2.55 (p=0.008)) in AMD group but not in NV group (ΔlogCS: 0, ΔBCVA: 0.24, (p=1.0)). Under glare conditions the improvement in CS was not significant with BLBF or NDF. The improvement in CS was significantly greater in the AMD group than in the NV group using CCP (ΔlogCS: 0.35 vs. -0.14 (P< 0.05)).The improvement of CS in cataract group was significantly better than in IOL group (ΔlogCS: 0.15 vs. -0.11 (p=0.01)).

Conclusions: : CS and BCVA can be used as objective parameters to evaluate the usefulness of BLBF. The results in this study suggest that BLBF improve the quality of vision in patients with AMD.

Keywords: contrast sensitivity • age-related macular degeneration • quality of life 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.